IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.180
-0.020 (-1.67%)
At close: Nov 4, 2024, 4:00 PM
1.190
+0.010 (0.85%)
After-hours: Nov 4, 2024, 4:36 PM EST
IO Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 78 | 124 | 66 | 184 | - | - |
| Market Cap Growth | 36.83% | 86.88% | -64.06% | - | - | - |
| Enterprise Value | -20 | -39 | -82 | 268 | - | - |
| Last Close Price | 1.20 | 1.88 | 2.30 | 6.40 | - | - |
| PE Ratio | - | -0.95 | -0.93 | -0.37 | - | - |
| PB Ratio | 0.82 | 0.93 | 0.48 | 0.87 | - | - |
| P/FCF Ratio | -0.95 | -1.72 | -1.10 | -4.52 | - | - |
| P/OCF Ratio | -0.96 | -1.73 | -1.11 | -4.54 | - | - |
| EV/EBITDA Ratio | 0.41 | 0.43 | 1.15 | -6.50 | - | - |
| EV/EBIT Ratio | 0.41 | 0.43 | 1.15 | -6.50 | - | - |
| EV/FCF Ratio | 0.48 | 0.54 | 1.36 | -6.57 | - | - |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | - | - | -5.89 |
| Debt / FCF Ratio | -0.03 | -0.03 | -0.05 | - | - | -0.97 |
| Quick Ratio | 7.42 | 9.18 | 13.50 | 20.73 | 1.61 | 0.84 |
| Current Ratio | 7.84 | 9.37 | 13.88 | 21.52 | 1.85 | 0.87 |
| Return on Equity (ROE) | -87.66% | -63.29% | -40.74% | -63.28% | -2127.56% | - |
| Return on Assets (ROA) | -50.98% | -37.78% | -23.87% | -22.61% | -84.12% | - |
| Return on Capital (ROIC) | -56.75% | -41.22% | -25.25% | -24.03% | -129.47% | - |
| Earnings Yield | -111.32% | -69.50% | -107.82% | -36.81% | - | - |
| FCF Yield | -102.28% | -58.18% | -91.16% | -22.12% | - | - |
| Buyback Yield / Dilution | -115.42% | -51.10% | -564.62% | -2346.74% | - | - |
| Total Shareholder Return | -115.42% | -51.10% | -564.62% | -2346.74% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.